Cargando…
Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196408/ https://www.ncbi.nlm.nih.gov/pubmed/36628987 http://dx.doi.org/10.1002/psp4.12906 |
| _version_ | 1785044347136245760 |
|---|---|
| author | Manolis, Efthymios García‐Arieta, Alfredo Lindahl, Anders Kotzagiorgis, Evangelos Limberg, Jobst Holte, Øyvind Paixao, Paulo Versantvoort, Carolien Tshinanu, Flora Musuamba Blake, Kevin Van Den Heuvel, Michiel |
| author_facet | Manolis, Efthymios García‐Arieta, Alfredo Lindahl, Anders Kotzagiorgis, Evangelos Limberg, Jobst Holte, Øyvind Paixao, Paulo Versantvoort, Carolien Tshinanu, Flora Musuamba Blake, Kevin Van Den Heuvel, Michiel |
| author_sort | Manolis, Efthymios |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10196408 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101964082023-05-20 Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective Manolis, Efthymios García‐Arieta, Alfredo Lindahl, Anders Kotzagiorgis, Evangelos Limberg, Jobst Holte, Øyvind Paixao, Paulo Versantvoort, Carolien Tshinanu, Flora Musuamba Blake, Kevin Van Den Heuvel, Michiel CPT Pharmacometrics Syst Pharmacol Perspectives John Wiley and Sons Inc. 2023-01-11 /pmc/articles/PMC10196408/ /pubmed/36628987 http://dx.doi.org/10.1002/psp4.12906 Text en © 2023 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Perspectives Manolis, Efthymios García‐Arieta, Alfredo Lindahl, Anders Kotzagiorgis, Evangelos Limberg, Jobst Holte, Øyvind Paixao, Paulo Versantvoort, Carolien Tshinanu, Flora Musuamba Blake, Kevin Van Den Heuvel, Michiel Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective |
| title | Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective |
| title_full | Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective |
| title_fullStr | Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective |
| title_full_unstemmed | Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective |
| title_short | Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective |
| title_sort | using mechanistic models to support development of complex generic drug products: european medicines agency perspective |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196408/ https://www.ncbi.nlm.nih.gov/pubmed/36628987 http://dx.doi.org/10.1002/psp4.12906 |
| work_keys_str_mv | AT manolisefthymios usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT garciaarietaalfredo usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT lindahlanders usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT kotzagiorgisevangelos usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT limbergjobst usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT holteøyvind usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT paixaopaulo usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT versantvoortcarolien usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT tshinanufloramusuamba usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT blakekevin usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective AT vandenheuvelmichiel usingmechanisticmodelstosupportdevelopmentofcomplexgenericdrugproductseuropeanmedicinesagencyperspective |